Study to Evaluate the Long‑Term Safety, Tolerability and Efficacy of Subcutaneous Marstacimab in Subjects With Severe Hemophilia

A Multicenter, Open‑Label Study to Evaluate the Long‑Term Safety, Tolerability and Efficacy of Subcutaneous PF‑06741086 in Subjects With Severe Hemophilia

Category & Conditions:
Rare Diseases
Medicine:
marstacimab (PF-06741086)
ClinicalTrials.gov Identifier (NCT):
Protocol ID:
B7841003
Open Plain Language Summary Result:Click here